Injectable Delivery Articles & Analysis
7 news found
Research institutions focusing on pharmaceutical formulation, cosmetic development, and healthcare solutions will find value in their specialized services, which include: l Advanced Drug Delivery System Development: Targeted drug delivery, injectable formulations, and more. l Pharmaceutical Analytical Methods and Testing Services: Comprehensive ...
Clearside intends to use the proceeds from the agreement to support ongoing clinical development of its pipeline, including CLS-AX (axitinib injectable suspension) administered by suprachoroidal injection via Clearside’s SCS Microinjector®. ...
ApiJect Holdings, Inc., the parent company of ApiJect Systems, Corp., a medical technology public-benefit corporation transforming the fill and finish and delivery of injectable vaccines and medicines, announced today that it had completed a $111 million private round of investment. ...
The trial will assess the safety, tolerability and immunogenicity of an MR vaccine delivered using Micron’s technology, compared with delivery via standard subcutaneous injection, in adults and children. The Company-sponsored Phase 1/2 trial will be conducted at the Medical Research Council Unit The Gambia (“MRCG”) under the leadership of Ed ...
Shining in this dynamic and ever changing space and in recognition of the organisations ability and commitment to innovate in the safety medical devices space Numedico Technologies has been awarded as the: Best Injectable Delivery Systems Wholesaler - Asia Pacific Neville Calvert, MD of Numedico Technologies said of the award and recognition; "Numedico ...
While the majority of COVID-19 vaccines in development today are delivered via intramuscular injection, research has demonstrated that nasal delivery – often the initial site of the infection – can prevent the virus from taking hold in the body. Preclinical research demonstrated that BlueWillow’s nasal vaccine adjuvant combined with ...
The company’s IOP Connect™ system is based on a long-term implantable sensor, smaller than a grain of rice, that is delivered to the eye by injection during a five-minute in-office procedure. The BDP designation is intended to help patients and physicians receive more timely access to breakthrough technologies that have the potential to provide more effective ...